GenieMD Awarded Frost & Sullivan’s 2024 Company of the Year Award for Pioneering Virtual Chronic Disease Management Solutions Through Its Unified Virtual Care Platform
San Antonio, TX — March 25, 2024 — Frost & Sullivan recently researched the North American virtual chronic disease management industry and, based on its findings, recognizes GenieMD with the 2024 Company of the Year Award. GenieMD is an American global provider of...
Harnessing Frost RadarTM for Robust Competitive Benchmarking in Data Centers and Colocation Services
Where Does Your Organization’s Growth Strategy for Data Centers and Colocation Services Stand vis-a-vis Your Competitors? In today’s digital economy, public cloud service providers, enterprises, and governments find themselves increasingly reliant on...
Are You Optimizing Your Growth Strategy to Leverage Key Opportunities in Military Artificial Intelligence?
Artificial intelligence (AI) and machine learning (ML) are transforming the defense industry. In today’s geopolitical chaos, these disruptive technologies offer a strategic advantage by providing real-time, tailored information critical for military commanders to make...
How Are You Capitalizing on the Expanding Digital & Software Mobility Ecosystem to Fortify Your Growth Pipeline?
The transformative landscape of software and digital mobility is unveiling one of the most diverse business ecosystems within the automotive industry. Forward-thinking original equipment manufacturers (OEMs) are spearheading this evolution, envisioning fully...
Does the Collapse of Maas Global and its all-inclusive MaaS solution, the Whim Travel App, Signify the End of the Road for Mobility as a Service Model?
MaaS is here to stay as an integral part of multimodal urban mobility but will require a rethink on business model, financial and operational strategies. Finnish mobility startup, Maas Global, and creator of the pioneering travel app Whim, has filed for bankruptcy one...
Are You Leveraging the Drug Discovery and Early Development Outsourcing Services Ecosystem to Accelerate Growth?
As of April 2023, the global pharmaceutical R&D pipeline has over 6000 molecules in active clinical development phase, showing a 5.8% increase from 2022. However, the pharma/biopharma industry shows overall stagnant R&D activity. Total R&D expenditure is...
Is your company actively benchmarking its performance against the key players in Healthcare IoT Security?
The Internet of Medical Things (IoMT) security industry is undergoing significant transformation driven by various factors. From the proliferation of Internet of Things (IoT) devices to evolving cyber threats and stringent regulations, the landscape is evolving...
Are You Harnessing the Power of Data Visualization to Drive Your Innovation and Growth in the Electric Vehicle (EV) Realm?
Electric vehicles are rapidly gaining traction among consumers, corporations, transport companies, and even in logistics and off-highway applications — quickly obsoleting traditional powertrains. This transformative shift is giving rise to a vast ecosystem of...
